A Crossover Study in the Treatment of Patients With COPD
Completed
Dey
Phase 3
2007-05-01
The purpose of this study is to compare the efficacy of Formoterol Fumarate Inhalation
Solution (FFIS) 20 mcg BID to Combivent® Inhalation Aerosol [2 inhalations from metered dose
inhaler (MDI)of 18 mcg ipratropium bromide and 103 mcg albuterol sulfate QID], and to Compare
the preference/compliance of BID nebulization to QID use of MDI
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
Completed
University of Texas Southwestern Medical Center
Phase 4
2012-01-01
The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as
a vehicle for albuterol in children with moderate to severe asthma exacerbation.
A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Completed
Boehringer Ingelheim
Phase 2
2000-10-01
Study to demonstrate the comparability of two puffs of Combivent hydrofluoroalkane (HFA)
inhalation aerosol (18 mcg ipratropium bromide/100 mcg albuterol sulfate / per puff) to two
puffs of the marketed chlorofluorocarbon (CFC) containing product, Combivent (CFC) inhalation
aerosol (18 mcg ipratropium bromide/103 mcg albuterol sulfate / per puff). The dose response
profile, safety and pharmacokinetics of Combivent HFA formulation are to be characterized.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
